FDA expands its import alert for supplements containing undeclared drug ingredients
The July update covers products marketed for sexual enhancement, weight loss, muscle building and other uses.
Anecdotal editorial image
The answer first
The FDA’s 9 July import alert allows listed products marketed as foods or supplements to be detained without physical examination when they contain undeclared active pharmaceutical ingredients.
Why it matters
The risk is not only that a claim is exaggerated. Some products sold as supplements can contain drug ingredients that are absent from the label, changing interaction and dosing risk.
What the alert covers
FDA investigations and laboratory analyses have identified products marketed as dietary supplements that contain undeclared pharmaceutical ingredients. The alert describes examples including anticoagulants, anticonvulsants and cholesterol-lowering drugs, alongside products promoted for weight loss, sexual enhancement and muscle building.
Products can be detained at the border when they meet the alert’s criteria. The live FDA record contains the affected firms and products; that operational list is more useful than a static reproduction.
Why labels cannot answer every safety question
An undeclared ingredient creates a different problem from a weak evidence claim. Consumers and clinicians cannot account for interactions or exposure if the active substance is missing from the label.
Anecdotal treats these notices as safety updates, not as general judgments about every product in the same category. The relevant questions are the named product, manufacturer, ingredient finding and current regulatory action.
The alert is operational guidance for FDA field staff and should be read with its live product list.
Primary sources
Check the underlying record.
- 01Import Alert 54-16regulator
US Food and Drug Administration · 2026-07-09
Keep following the change
Get the most material safety & regulation updates in the free Anecdotal Briefing.
We never sell or share your email. Unsubscribe in one click.
Keep reading
Related intelligence.
The US moringa-powder Salmonella outbreak is over—but recalled products may remain
The FDA and CDC closed the investigation after 131 reported cases across 38 states. The products have long shelf lives.
FDA says Addall supplements contained undeclared stimulant-like ingredients
Testing found DMAA, DMHA and phenibut across two products; only one was voluntarily recalled.
The UK has rewritten its consumer guide to food supplements
The June guidance explains authorised claims, interactions and why supplement labels cannot promise to treat symptoms.